Nutritional Strategies for Battling Obesity-Linked Liver Disease: the Role of Medical Nutritional Therapy in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management

被引:17
作者
Simancas-Racines, Daniel [1 ]
Annunziata, Giuseppe [2 ]
Verde, Ludovica [3 ]
Fasci-Spurio, Federica [4 ]
Reytor-Gonzalez, Claudia [1 ]
Muscogiuri, Giovanna [5 ,6 ,7 ]
Frias-Toral, Evelyn [8 ]
Barrea, Luigi [9 ]
机构
[1] Univ UTE, Fac Ciencias Salud Eugenio Espejo, Ctr Invest Salud Publ & Epidemiol Clin CISPEC, Quito 170527, Ecuador
[2] Univ Telemat Pegaso, Fac Sci Umane Formaz & Sport, Via Porzio,Ctr Direz,Isola F2, I-80143 Naples, Italy
[3] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy
[4] Osped Angelo, Gastroenterol Unit, Venice, Italy
[5] Univ Napoli Federico II, Dipartimento Med Clin & Chirurg, Unita Endocrinol Diabetol & Androl, Via Sergio Pansini 5, I-80131 Naples, Italy
[6] Univ Napoli Federico II, Ctr Italiano Cura & Benessere Paziente Con Obes CI, Dipartimento Med Clin & Chirurg, Unita Endocrinol Diabetol & Androl, Via Sergio Pansini 5, I-80131 Naples, Italy
[7] Univ Federico II, Cattedra Unesco Educ Salute & Allo Sviluppo Sosten, I-80131 Naples, Italy
[8] Univ Espiritu Santo, Escuela Med, Samborondon 0901952, Ecuador
[9] Univ Telemat Pegaso, Dipartimento Psicol & Sci Salute, Ctr Direz Isola F2,Via Porzio, I-80143 Naples, Italy
关键词
Obesity; Medical Nutritional Therapy (MNT); Metabolic-Associated Steatotic Liver Disease (MASLD); Mediterranean diet; Nutraceutical supplementation; Liver fibrosis; NONALCOHOLIC FATTY LIVER; HEALTHY EATING INDEX; WEIGHT-LOSS; DIETARY FIBER; LIFE-STYLE; INSULIN-RESISTANCE; PRACTICE GUIDANCE; PATHOPHYSIOLOGY; PREVALENCE; FIBROSIS;
D O I
10.1007/s13679-024-00597-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of ReviewThis narrative review explores the role of Medical Nutritional Therapy (MNT) in managing Metabolic-Associated Steatotic Liver Disease (MASLD), previously known as nonalcoholic fatty liver disease. It aims to examine the effectiveness of specific nutritional strategies in preventing and treating this obesity-linked liver disease.Recent FindingsEmerging evidence underscores the benefits of the Mediterranean diet, low-carbohydrate diets, and intermittent fasting in reducing liver fat, improving insulin sensitivity, and mitigating inflammation. Supplementing with vitamin E, omega-3 fatty acids, and silymarin can potentially reduce liver fibrosis and promote liver health.SummaryMNT is a key intervention for MASLD management, emphasizing dietary patterns, caloric restriction, and nutraceutical supplementation. Integrating these strategies with lifestyle modifications, including regular physical activity, offers a comprehensive approach to improving metabolic and liver outcomes in patients with MASLD. Further research is needed to refine and personalize these therapeutic interventions.
引用
收藏
页数:16
相关论文
共 127 条
[1]   The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation [J].
Abenavoli, Ludovico ;
Gambardella, Maria Luisa ;
Scarlata, Giuseppe Guido Maria ;
Lenci, Ilaria ;
Baiocchi, Leonardo ;
Luzza, Francesco .
MEDICINA-LITHUANIA, 2024, 60 (04)
[2]   Intermittent fasting regimens for metabolic dysfunction-associated steatotic liver disease: a systematic review and network meta-analysis of randomized controlled trials [J].
Abuelazm, Mohamed T. ;
Mohamed, Islam ;
Naeem, Ahmed ;
Khlidj, Yehya ;
Tanashat, Mohammad ;
Katamesh, Basant E. ;
Abusuilik, Husam ;
Altobaishat, Obieda ;
Abdelnabi, Mohamed ;
Abdelazeem, Basel .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 36 (04) :371-381
[3]   Ramadan Fasting in Individuals with Metabolic Dysfunction-Associated Steatotic Liver Disease, Liver Transplant, and Bariatric Surgery: A Narrative Review [J].
Ahmed, Musaab ;
Ahmed, Mohamed H. .
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (13)
[4]   The gut-liver axis in liver disease: Pathophysiological basis for therapy [J].
Albillos, Agustin ;
de Gottardi, Andrea ;
Rescigno, Maria .
JOURNAL OF HEPATOLOGY, 2020, 72 (03) :558-577
[5]   Non-Pharmacological Approach to Diet and Exercise in Metabolic-Associated Fatty Liver Disease: Bridging the Gap between Research and Clinical Practice [J].
Ali, Hassam ;
Shahzil, Muhammad ;
Moond, Vishali ;
Shahzad, Maria ;
Thandavaram, Abhay ;
Sehar, Alina ;
Waseem, Haniya ;
Siddiqui, Taha ;
Dahiya, Dushyant Singh ;
Patel, Pratik ;
Tillmann, Hans .
JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (01)
[6]   Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting [J].
Allen, Alina M. ;
Charlton, Michael ;
Cusi, Kenneth ;
Harrison, Stephen A. ;
Kowdley, Kris V. ;
Noureddin, Mazen ;
Shubrook, Jay H. .
POSTGRADUATE MEDICINE, 2024, 136 (03) :229-245
[7]   Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease [J].
Angulo, Paul ;
Kleiner, David E. ;
Dam-Larsen, Sanne ;
Adams, Leon A. ;
Bjornsson, Einar S. ;
Charatcharoenwitthaya, Phunchai ;
Mills, Peter R. ;
Keach, Jill C. ;
Lafferty, Heather D. ;
Stahler, Alisha ;
Haflidadottir, Svanhildur ;
Bendtsen, Flemming .
GASTROENTEROLOGY, 2015, 149 (02) :389-+
[8]   Intermittent fasting: a new trend or a valid approach for the treatment of obesity? [J].
Annunziata, Giuseppe ;
Capo, Xavier ;
Muscogiuri, Giovanna ;
Colao, Annamaria ;
Barrea, Luigi .
MINERVA ENDOCRINOLOGY, 2023, 48 (04) :367-370
[9]  
[Anonymous], Obesity and overweight
[10]   Short-term reduction of dietary gluten improves metabolic-dysfunction associated steatotic liver disease: A randomised, controlled proof-of-concept study [J].
Armandi, Angelo ;
Bespaljko, Helena ;
Mang, Alexander ;
Huber, Yvonne ;
Michel, Maurice ;
Labenz, Christian ;
Galle, Peter R. ;
Neerukonda, Manjusha ;
Bugianesi, Elisabetta ;
Schuppan, Detlef ;
Schattenberg, Joern M. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (10) :1212-1222